Faced with the coronavirus pandemic, restrictions and ever-fluctuating situations have necessitated changes to ongoing and
future clinical trials. Nariné Baririan at SGS explains why practical and harmonised actions have been required to ensure the necessary flexibility in trial facilities, and adaptations to regular procedures have been needed to maintain the integrity of the trials.